Published in Ann Intern Med on July 01, 1981
Plasmapheresis in clinical medicine. West J Med (1983) 0.77
Long-term hematopoietic damage: concepts, approaches, and results relevant to the study of environmental toxins. Environ Health Perspect (1989) 0.75
Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A (1998) 3.35
Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol (1976) 3.08
Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion. Ann Intern Med (1973) 3.07
Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest (1981) 2.24
Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo. N Engl J Med (1977) 2.16
Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. J Clin Invest (1978) 1.93
Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study) JPEN J Parenter Enteral Nutr (1994) 1.63
Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse. Lupus (2009) 1.60
Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopathol (1998) 1.52
The thymus in myasthenia gravis. Evidence for altered cell populations. N Engl J Med (1974) 1.50
Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. J Clin Invest (1979) 1.49
Cells involved in the immune response. VI. The immune response to red blood cells in irradiated rabbits after administration of normal, primed, or immune allogeneic rabbit bone marrow cells. J Exp Med (1969) 1.48
Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood (1976) 1.44
V gene sequences of lupus-derived human IgM anti-ssDNA antibody: implication for the importance of the location of DNA-binding amino acids. Clin Immunol Immunopathol (1998) 1.39
Alkylating agents as leukemogens in multiple myeloma. Cancer (1974) 1.20
The effect of dietary protein depletion on immunocompetence: the importance of nutritional repletion prior to immunologic induction. Ann Surg (1974) 1.19
The effects of protein calorie malnutrition on immune competence of the surgical patient. Surg Gynecol Obstet (1974) 1.18
Effects of azathioprine therapy on bone marrow-dependent and thymus-dependent cells in man. Clin Exp Immunol (1973) 1.17
The monoclonal nature of lymphocytes in multiple myeloma. Effects of therapy. Ann Intern Med (1975) 1.17
The role of bone marrow in the immune response. Adv Immunol (1970) 1.16
T and B lymphocytes in multiple sclerosis. Clin Exp Immunol (1975) 1.09
Immunoglobulin (Ig) receptors on human peripheral leukocytes. II. Class restriction Ig receptors. J Immunol (1971) 1.09
Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol (2005) 1.07
Suppressor T cell dysfunction and anti-suppressor cell antibody in active early rheumatoid arthritis. J Rheumatol (1981) 1.05
Human bone marrow lymphocytes: B and T cell precursors and subpopulations. Blood (1976) 1.04
Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study. J Clin Oncol (1983) 1.04
Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty's syndrome. Arthritis Rheum (1983) 1.01
Bone marrow: the bursa equivalent in man? Science (1972) 1.01
Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol (1997) 1.00
Suppressor cell-mediated neutropenia in Felty's syndrome. J Clin Invest (1978) 0.98
Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. J Rheumatol (1998) 0.98
Study of anti-DNA antibodies prepared by DNA cellulose or Cibacron blue chromatography. J Immunol Methods (1986) 0.97
Comparative study of the in vitro proliferative responses of blood and synovial fluid leukocytes of rheumatoid arthritis patients. J Clin Invest (1973) 0.97
Cells involved in the immune response. XV. The organ source of the antigen reactive cells in the normal rabbit. Int Arch Allergy Appl Immunol (1970) 0.97
Secretory immunoglobulin deficiency in a family with inflammatory bowel disease. Gastroenterology (1978) 0.97
Aspects of lymphocyte function in myasthenia gravis. Ann N Y Acad Sci (1976) 0.95
Anit-immunoglobulins in multiple myeloma. Clin Exp Immunol (1972) 0.95
Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol (2001) 0.95
Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis. Infection (1978) 0.95
Histoplasma meningitis with hyperactive suppressor T cells in cerebrospinal fluid. Neurology (1978) 0.93
Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. Cancer Treat Rep (1982) 0.93
Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol (2001) 0.92
Immunologic studies of a spontaneous syngeneic tumor-host system. II. Specific immune tolerance and adoptive tolerance by thymic grafts. Int Arch Allergy Appl Immunol (1968) 0.92
Nonspecific suppressor cell function in atopic subjects. J Allergy Clin Immunol (1979) 0.92
Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol (2000) 0.91
Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant (1996) 0.91
Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunol (1993) 0.90
Polymyositis with hypokalemia: correction with potassium replacement in the absence of steroids. J Rheumatol (1987) 0.90
Relationship of immunoglobulin to complement receptors of human B cells. J Immunol (1974) 0.89
Cells involved in the immune response. V. The migration of antigen-reactive immunocompetent cells out of the bone marrow following antigen administration. Int Arch Allergy Appl Immunol (1969) 0.89
Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease. J Lab Clin Med (1978) 0.89
Platelet preservation by freezing. Use of dimethylsulfoxide as cryoprotective agent. Transfusion (2003) 0.88
Cells involved in the immune response. XI. Identification of the antigen-reactive cell as the tolerant cell in the immunologically tolerant rabbit. J Exp Med (1969) 0.88
Growth suppression of human leukemic cells in vitro by L-ascorbic acid. Cancer Res (1980) 0.88
Pure red cell aplasia associated with B cell lymphoma: demonstration of bone marrow colony inhibition by serum immunoglobulin. Leuk Res (1990) 0.87
Null cells in peripheral blood of normals and systemic lupus erythematosus. Clin Immunol Immunopathol (1976) 0.87
Cells involved in the immune response, IX. Depletion from the normal rabbit bone marrow of antigen-reactive cells directed toward human peripheral leukocytes. Proc Natl Acad Sci U S A (1969) 0.87
Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin. Am J Hematol (1978) 0.87
Cells involved in the immune response. 8. The relationship between the loss and reappearance of antigen-reactive cells and immune responsiveness after irradiation of normal adult rabbits. J Exp Med (1969) 0.86
Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism. J Clin Endocrinol Metab (1975) 0.86
The idiotype-antiidiotype network in human autoimmunity. J Clin Immunol (1985) 0.86
Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: a Southwest Oncology Group Study. Cancer (1981) 0.85
Anti-(DNA-histone) antibodies in active lupus nephritis. J Rheumatol (1996) 0.85
Idiotypic and immunochemical differences of anti-DNA antibodies of a lupus patient during active and inactive disease. Clin Immunol Immunopathol (1991) 0.85
Multiple myeloma associated with immune thrombocytopenic purpura. Cancer (1985) 0.84
Extracellular signal-regulated kinase 1/2 signalling in SLE T cells is influenced by oestrogen and disease activity. Lupus (2008) 0.84
Comparative study of bone marrow and blood B cells in infantile and acquired agammaglobulinemia. Possible role of circulating anti-IgM in pathogenesis. J Clin Invest (1973) 0.84
Specific immunoregulation abnormality in insulin-dependent diabetes mellitus. J Lab Clin Med (1982) 0.83
Immunoglobulin receptors on human leucocytes. 3. Comparative study of human bone marrow and blood B cells: role of IgM receptors. Clin Exp Immunol (1973) 0.83
Detection and purification of antiidiotypic antibody against anti-DNA in intravenous immune globulin. J Clin Immunol (1991) 0.82
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents. Blood (1992) 0.82
Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res (1983) 0.82
Hidradenitis suppurativa: evidence for a bactericidal defect correctable by cholinergic agonist in vitro and in vivo. J Clin Immunol (1982) 0.82
Immunologic studies of a spontaneous syngeneic tumor-host system. I. The role of immune mechanisms in tumor transplants in the syngeneic host. Int Arch Allergy Appl Immunol (1969) 0.82
Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood (1980) 0.81
Histamine receptors on rabbit blastocyst and endometrial cell membranes. Nature (1979) 0.81
Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells. Lupus (2006) 0.81
Respiratory dysfunction in thrombotic thrombocytopenic purpura. Am J Med (1978) 0.80
Spontaneous shift of anti-DNA antibody idiotypes in systemic lupus erythematosus. J Immunol (1988) 0.80
The secondary antibody response in tissue culture. IV. Studies of the in vivo and in vitro antigenicity of native, aggregate-free and aggregated human gamma globulin in rabbits. Immunology (1970) 0.80
Private idiotypes on human polyclonal IgG anti-DNA antibodies are not expressed on coexisting IgM anti-DNA antibodies in systemic lupus erythematosus. Clin Immunol Immunopathol (1988) 0.79
Lupus-derived human monoclonal IgM anti-DNA antibody displays monospecificity, high affinity and private idiotype specificity. Lupus (1992) 0.79
Characterization of two anti-DNA antibodies bearing distinct idiotypes. Correlation with clinical manifestations. J Autoimmun (1989) 0.79
Immunoglobulin receptors on human leukocytes. IV. Differences between bone marrow and blood cells in multiple myeloma and chronic lymphocytic leukemia: effects of therapy. J Lab Clin Med (1973) 0.79
Cellular and humoral immune parameters of synovial fluid and blood in rheumatoid arthritis. J Rheumatol (1975) 0.79
Lymphocyte studies in a patient with chronic polyradiculoneuropathy. Neurology (1982) 0.79